MyNorthwest

News

Opinion

Sports

Tools

Connect

Pfizer rides Paxlovid sales to better-than-expected quarter

FILE - DeMarcus Hicks, a recent graduate of nursing school who is working as a contractor with the Federal Emergency Management Agency, gives a person a Pfizer COVID-19 vaccine booster shot, Dec. 20, 2021, in Federal Way, Wash. A federal appeals court in New Orleans on Monday, Oct. 3, 2022, became the latest to hear arguments on whether President Joe Biden overstepped his authority with an order that federal contractors require that their employees be vaccinated against COVID-19. (AP Photo/Ted S. Warren, File)

FILE - A woman walks by Pfizer headquarters, Friday, Feb. 5, 2021 in New York. Pfizer reports quarterly financial results Tuesday, Nov. 1, 2022. (AP Photo/Mark Lennihan, File)

FILE - A syringe is placed into a vial of Pfizer-BioNTech vaccination at a COVID-19 clinic in Augusta, Maine, on Tuesday, Dec. 21, 2021. On Thursday, Oct. 20, 2022, Pfizer said it will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving doses for free. (AP Photo/Robert F. Bukaty, File)

Pfizer rides Paxlovid sales to better-than-expected quarter